
    
      The objective of this exploratory study is to assess the benefits of memantine compared to
      placebo in out-patients with a diagnosis of Parkinson's Disease Dementia or Dementia with
      Lewy Bodies (mild to moderate severity) over a 6-month period. This is a multinational,
      randomised, double-blind, parallel-group, placebo-controlled, fixed-dose study with specific
      cognitive (attention, executive function, visual perception and memory), behavioural,
      functional and global measures.
    
  